Primary PreventionNCT04977154
Prevention in Belgian Hockey : What Does the Staff Really Put in Place?
An observational study of Primary Prevention and Questionnaire and Survey, run by University of Liege at 1 site in Belgium.
Trial summary
Purpose: To provide an update on the implementation of prevention among hockey players by their entourage. Materiel and method: This study will be conducted by the means of a questionnaire. The target population consisted of trainers. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Primary Prevention, Questionnaire and Survey, Hockey Player
- What is being tested?
- Primary prevention
- How many people
- 60 participants
- Where
- 1 siteBelgium
- Study dates
- 1 Jul 2021to Jul 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Hockey trainer at different level of play
Who may be able to join
- Professions: hockey trainer
Who cannot join
- /
Trial locations and contacts
1 site in 1 country.
Belgium1 site, 1 recruiting
- Recruiting
University of Liège
Liège, 4000
Amandine Gofflot, +3243662193, agofflot@uliege.be
About this study
Purpose: To provide an update on the implementation of prevention among hockey players by their entourage.
Materiel and method: This study will be conducted by the means of a questionnaire. The target population consisted of trainers.
The questionnaire will be validated by experts and published on an online survey website
- Conditions
- Primary Prevention, Questionnaire and Survey, Hockey Player
- Being tested
- Primary prevention
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Primary preventionOther
The primary prevention that the trainers put in place for the hockey players
| Study group | Role | What they receive |
|---|---|---|
| Trainers | Not described Receives: Other: Primary prevention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Primary prevention by a questionnaire
The trainers will respond to a questionnaire that will inform us about the primary prevention that they put in place in hockey.
Measured: Time Frame: The questionnaire will last 15 minutes at most
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jul 2021
- Study start1 Jul 2021
- Primary completionJun 2024 (estimated)
- Study completionJul 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Primary PreventionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Liege
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gofflot Amandine, University of Liege
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04977154
- Sponsor's protocol ID
- 160521
- Status last verified
- Jan 2024
- First submitted
- 13 Jul 2021
- Last updated
- 3 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevention in Belgian Hockey : What Does the Staff Really Put in Place?
- ClinicalTrials.gov ID
- NCT04977154
- Acronym / sponsor ID
- 160521
- Conditions
- Primary Prevention, Questionnaire and Survey, Hockey Player
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- University of LiegeUniversity, hospital or other
- Study start
- 1 Jul 2021 (actual)
- Primary completion
- Jun 2024 (estimated)
- Study completion
- Jul 2024 (estimated)
- First posted
- 26 Jul 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Purpose: To provide an update on the implementation of prevention among hockey players by their entourage.
Materiel and method: This study will be conducted by the means of a questionnaire. The target population consisted of trainers.
The questionnaire will be validated by experts and published on an online survey website
Study design
- Observational model
- Cohort
- Time perspective
- Other
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Trainers | – | Other: Primary prevention |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Hockey trainer at different level of play
Key inclusion criteria (1 listed)
- Professions: hockey trainer
Key exclusion criteria (1 listed)
- /
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Primary preventionThe primary prevention that the trainers put in place for the hockey players | Other | Trainers |
Primary outcome
Primary prevention by a questionnaire
Time frame: Time Frame: The questionnaire will last 15 minutes at most
The trainers will respond to a questionnaire that will inform us about the primary prevention that they put in place in hockey.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jan 2024.
Related trials for Primary Prevention
Not yet recruitingObservational study
Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
Abdominal Aortic Aneurysm, Morbid Obesity
Not yet recruiting
Is Routine Dental Clearance or Antibiotic Prophylaxis Before Dental Procedures Necessary in Total Joint Arthroplasty?
Elective Primary THA or TKA
Recruiting
Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial (CVRISK-IT)
Cardiovascular Risk, Genetic Cardiovascular Risk
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
Enrolling by invitation
The DANE-HEART Trial - Computed Tomography Coronary Angiography for Primary Prevention
Coronary Atherosclerosis and Other Heart Disease, Cardiovascular Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Primary Prevention and Questionnaire and Survey, run by University of Liege at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 3 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Amandine Gofflot (+3243662193, agofflot@uliege.be), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Primary prevention by a questionnaire (time frame: Time Frame: The questionnaire will last 15 minutes at most). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2024.